Table 3 Adverse events associated with DCF-ICT (CTCAE ver 4.0)
Grade 1, n (%) | Grade 2, n (%) | Grade 3, n (%) | Grade 4, n (%) | All, n (%) | |
|---|---|---|---|---|---|
Anorexia | 10 (20.8) | 13 (27.1) | 12 (25.0) | 0 | 35 (72.9) |
Fatigue | 22 (45.8) | 9 (18.8) | 1 (2.1) | 0 | 32 (66.7) |
Nausea | 19 (39.6) | 10 (20.8) | 2 (4.2) | 0 | 31 (64.6) |
Diarrhoea | 5 (10.4) | 9 (18.8) | 5 (10.4) | 0 | 19 (39.6) |
Mucositis oral | 12 (25.0) | 6 (12.5) | 0 | 0 | 18 (37.5) |
Dysphagia | 7 (14.6) | 4 (8.3) | 2 (4.2) | 0 | 13 (27.1) |
Febrile neutropenia | — | — | 11 (22.9) | 0 | 11 (22.9) |
Vomiting | 8 (16.7) | 1 (2.1) | 0 | 0 | 9 (18.8) |
Oesophageal fistula | 0 | 0 | 2 (4.2) | 0 | 2 (4.2) |
White blood cell decreased | 4 (8.3) | 14 (29.2) | 15 (31.3) | 5 (10.4) | 38 (79.2) |
Neutrophil count decreased | 1 (2.1) | 7 (14.6) | 10 (20.8) | 22 (45.8) | 40 (83.3) |
Anaemia | 29 (60.4) | 14 (29.2) | 0 | 0 | 43 (89.6) |
Platelet count decreased | 12 (25.0) | 1 (2.1) | 0 | 1 (2.1) | 14 (29.2) |
Aspartate aminotransferase increased | 17 (35.4) | 0 | 0 | 0 | 17 (35.4) |
Alanine aminotransferase increased | 15 (31.3) | 2 (4.2) | 1 (2.1) | 0 | 18 (37.5) |
Creatinine increased | 11 (22.9) | 3 (6.3) | 0 | 0 | 14 (29.2) |
Hyponatremia | 22 (45.8) | 0 | 6 (12.5) | 1 (2.1) | 29 (60.4) |
